Xiaowen Shen

发表

Homology-mediated end joining-based targeted integration using CRISPR/Cas9

Qiang Sun, Pengyu Huang, Wenqin Ying, 2017, Cell Research.

An engineered xCas12i with high activity, high specificity, and broad PAM range

Han Yang, Zikang Wang, Xiaowen Shen, 2022, bioRxiv.

Fiber degradation potential of natural co-cultures of Neocallimastix frontalis and Methanobrevibacter ruminantium isolated from yaks (Bos grunniens) grazing on the Qinghai Tibetan Plateau.

Xiaowen Shen, R. Long, Hong-Jian Yang, 2016, Anaerobe.

Endogenous promoter-driven sgRNA for monitoring the expression of low-abundance transcripts and lncRNAs

Yidi Sun, Hui Yang, Xinde Hu, 2021, Nature Cell Biology.

Endogenous promoter-driven sgRNA for monitoring the expression of low-abundance transcripts and lncRNAs

Yidi Sun, Hui Yang, Xinde Hu, 2021, Nature Cell Biology.

In vivo simultaneous transcriptional activation of multiple genes in the brain using CRISPR–dCas9-activator transgenic mice

Huatai Xu, Yidi Sun, Pengyu Huang, 2018, Nature Neuroscience.

Disruption of splicing-regulatory elements using CRISPR/Cas9 to rescue spinal muscular atrophy in human iPSCs and mice

A. Krainer, Yidi Sun, Min-ting Lin, 2019, National science review.

CRISPR/Cas9 – Mediated Precise Targeted Integration In Vivo Using a Double Cut Donor with Short Homology Arms

Xin Wang, Hui Yang, Pengyu Huang, 2017, EBioMedicine.

Engineered CRISPR-OsCas12f1 and RhCas12f1 with robust activities and expanded target range for genome editing

Yuan Yuan, Zikang Wang, Hui Yang, 2023, Nature Communications.